Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
61
NCT02550678
A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma
Phase: Phase 1/2
Role: Lead Sponsor
Start: Sep 30, 2015
Completion: Nov 30, 2017
NCT03208296
Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS)
Start: Dec 1, 2017
Completion: Mar 31, 2025
NCT04416516
Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor
Phase: Phase 2
Start: Jul 16, 2020
Completion: Feb 14, 2024